Literature DB >> 3428297

Successful treatment of echovirus meningoencephalitis in sex-linked agammaglobulinaemia by intrathecal and intravenous injection of high titre gammaglobulin.

H Kondoh1, K Kobayashi, Y Sugio, T Hayashi.   

Abstract

A 7-year-old boy with sex-linked agammaglobulinaemia developed meningoencephalitis caused by echovirus type 11. He had convulsions, right hemiplegia, cortical motor aphasia, left abducens nerve paralysis, left hypoglossal nerve paralysis, and later became unconscious. Treatment by intravenous injection of conventional gammaglobulin and intrathecal alpha-interferon brought no clinical improvement, but intrathecal administration together with intravenous injection of gammaglobulin containing a high titre of anti-echovirus type 11 antibody was associated with a dramatic improvement in his clinical symptoms. After subsequent periodical (once or twice a week) administration of specific gammaglobulin for 8 months, the echovirus in his cerebrospinal fluid was no longer detected. These findings suggest that intrathecal injection combined with intravenous injection of high titre anti-echovirus type 11 antibody was effective in treating this case of echovirus meningoencephalitis in sex-linked agammaglobulinaemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428297     DOI: 10.1007/BF02467368

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  5 in total

1.  Chronic ECHO type 5 virus meningoencephalitis in X-linked hypogammaglobulinemia: treatment with immune plasma.

Authors:  J B Bodensteiner; H H Morris; J T Howell; S S Schochet
Journal:  Neurology       Date:  1979-06       Impact factor: 9.910

2.  Persistent and fatal central-nervous-system ECHOvirus infections in patients with agammaglobulinemia.

Authors:  C M Wilfert; R H Buckley; T Mohanakumar; J F Griffith; S L Katz; J K Whisnant; P A Eggleston; M Moore; E Treadwell; M N Oxman; F S Rosen
Journal:  N Engl J Med       Date:  1977-06-30       Impact factor: 91.245

3.  Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.

Authors:  P J Mease; H D Ochs; R J Wedgwood
Journal:  N Engl J Med       Date:  1981-05-21       Impact factor: 91.245

4.  Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin.

Authors:  K Erlendsson; T Swartz; J M Dwyer
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

5.  Effect of specific antibodies on chronic echovirus type 5 encephalitis in a patient with hypogammaglobulinemia.

Authors:  L S Weiner; J T Howell; M P Langford; G J Stanton; S Baron; R M Goldblum; R A Lord; A S Goldman
Journal:  J Infect Dis       Date:  1979-12       Impact factor: 5.226

  5 in total
  7 in total

Review 1.  Passive immunity in prevention and treatment of infectious diseases.

Authors:  M A Keller; E R Stiehm
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

3.  Intravitreal human immune globulin in a rabbit model of Staphylococcus aureus toxin-mediated endophthalmitis: a potential adjunct in the treatment of endophthalmitis.

Authors:  Dennis P Han
Journal:  Trans Am Ophthalmol Soc       Date:  2004

Review 4.  Chronic enteroviral meningoencephalitis in agammaglobulinemia: case report and literature review.

Authors:  S A Misbah; G P Spickett; P C Ryba; J M Hockaday; J S Kroll; C Sherwood; J B Kurtz; E R Moxon; H M Chapel
Journal:  J Clin Immunol       Date:  1992-07       Impact factor: 8.317

Review 5.  Role of the virology laboratory in diagnosis and management of patients with central nervous system disease.

Authors:  T Chonmaitree; C D Baldwin; H L Lucia
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

Review 6.  Therapeutic use of immunoglobulins.

Authors:  E Richard Stiehm; Jordan S Orange; Mark Ballow; Heather Lehman
Journal:  Adv Pediatr       Date:  2010

Review 7.  Efficacy and safety of intravenous immunoglobulins for the treatment of viral encephalitis: a systematic literature review.

Authors:  Judith N Wagner; Annette Leibetseder; Anna Troescher; Juergen Panholzer; Tim J von Oertzen
Journal:  J Neurol       Date:  2021-03-06       Impact factor: 6.682

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.